Canagliflozin, a sodium-glucose cotransporter 2 inhibitor, normalizes renal susceptibility to type 1 cardiorenal syndrome through reduction of renal oxidative stress in diabetic rats
| Image |  |
|---|---|
| Description | scientific article published on 25 February 2019 |
| Author/s |
author: Atsushi Kuno Takayuki Miki |
| Publication date | February 25, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |